Pharmaceutical giant GE Healthcare will pay $30 million to the U.S. Justice Department to settle claims in a case filed by a Michigan salesman, alleging one of its companies marketed a diagnostic drug used in cardiology tests as one that could be diluted and stretched to more patients than intended.
GE Healthcare to pay $30 million in false-claims settlement
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Recommended for You